You Can Expect BIOL To Post Outstanding Results On Or About May 6th When They Report Q1/2013
Don't look in the BIOL rear view mirror when assessing whether or not to climb aboard its stock. That would now be a huge mistake. Look in a forward direction as what is now coming down the pike. CEO Frederico Pignatelli and his team have put the company through a very dynamic and very positive operational change. That change which took place over the past 18 months is now going to bear fruit for investors in BIOL. I highly recommend purchase of this stock based upon what not only became visible in Q4/2012 but also what will unfold as we progress quarter to quarter through 2013 and 2014. BIOL is now a very higly interesting "growth" story that will deliver excellent bottom line performance for its investors. Make sure you take advantage of it.
IRVINE, CA--(Marketwire - Nov 8, 2012) - BIOLASE, Inc. ( NASDAQ : BIOL ), the world's leading dental laser manufacturer and distributor, ranked 25th in the Orange County Business Journal's 2012 Fastest-Growing Public Companies list. Rankings are based on percentage revenue growth for the 12-month period ended June 30, 2012 as compared with the 12-month period ended June 30, 2010. BIOLASE grew 58.5% during this period.
Companies must have recorded sales of at least $300,000 for the 12 months ended June 30, 2010. Furthermore, sales for the 12 months ended June 30, 2012, must represent at least 13% revenue growth as compared with the two-years prior period. Based on these criteria, 69 companies were included on the 2012 Fastest-Growing Public Companies list. The Orange County Business Journal compiled the financial data with the help of Los Angeles-based investment bank B. Riley & Co., along with regulatory filings and other sources.